Published in J Lipid Res on December 01, 1997
Human BSE. Nature (1997) 11.79
Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet (1992) 7.09
Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest (1989) 5.75
Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. J Clin Invest (2000) 5.07
Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J Biol Chem (1997) 3.91
Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation (1999) 3.53
Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest (2000) 3.51
Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study. Lancet (1999) 3.34
Early treatment with allopurinol in familial juvenile hyerpuricaemic nephropathy (FJHN) ameliorates the long-term progression of renal disease. QJM (2002) 3.09
Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein. Proc Natl Acad Sci U S A (1998) 2.93
Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. Am J Pathol (1991) 2.92
Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol (2001) 2.85
Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J Clin Invest (1999) 2.81
Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis (1990) 2.70
Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler Thromb (1994) 2.47
Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo. Arterioscler Thromb Vasc Biol (2001) 2.20
Enhanced antibody responses in active chronic hepatitis: relation to HLA-B8 and HLA-B12 and porto-systemic shunting. Lancet (1976) 1.89
Pre-eclampsia and serum antibodies to oxidised low-density lipoprotein. Lancet (1994) 1.88
Scavenger receptors, oxidized LDL, and atherosclerosis. Ann N Y Acad Sci (2001) 1.82
Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts. J Clin Invest (1991) 1.79
Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo. J Nucl Cardiol (1999) 1.78
Age-related effects on atherogenesis and scavenger enzymes of intracranial and extracranial arteries in men without classic risk factors for atherosclerosis. Stroke (2001) 1.66
Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. J Clin Invest (1996) 1.65
Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. Arterioscler Thromb Vasc Biol (1998) 1.57
Scavenger receptor A gene regulatory elements target gene expression to macrophages and to foam cells of atherosclerotic lesions. Proc Natl Acad Sci U S A (1995) 1.56
Western-type diets induce insulin resistance and hyperinsulinemia in LDL receptor-deficient mice but do not increase aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol levels are achieved by a fructose-rich diet. Arterioscler Thromb Vasc Biol (1999) 1.54
The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta2 glycoprotein 1 (and other proteins). Proc Natl Acad Sci U S A (1997) 1.51
The parallel Lack anaesthetic breathing system. Anaesthesia (1993) 1.41
In vivo uptake of radiolabeled MDA2, an oxidation-specific monoclonal antibody, provides an accurate measure of atherosclerotic lesions rich in oxidized LDL and is highly sensitive to their regression. Arterioscler Thromb Vasc Biol (2000) 1.36
Phosphate permeases of Saccharomyces cerevisiae: structure, function and regulation. Biochim Biophys Acta (1999) 1.30
Polymerase chain reaction-based method for quantifying recruitment of monocytes to mouse atherosclerotic lesions in vivo: enhancement by tumor necrosis factor-alpha and interleukin-1 beta. Arterioscler Thromb Vasc Biol (2000) 1.26
Multiple role of reactive oxygen species in the arterial wall. J Cell Biochem (2001) 1.25
Effect of streptozotocin-induced hyperglycemia on lipid profiles, formation of advanced glycation endproducts in lesions, and extent of atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol (1997) 1.25
Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficient and LDL receptor-deficient mice. J Pathol (2001) 1.20
Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol (2001) 1.14
Evidence that the lipid moiety of oxidized low density lipoprotein plays a role in its interaction with macrophage receptors. Proc Natl Acad Sci U S A (1998) 1.13
Intracranial arteries of human fetuses are more resistant to hypercholesterolemia-induced fatty streak formation than extracranial arteries. Circulation (1999) 1.12
An EGS4-ready tomographic computational model of a 14-year-old female torso for calculating organ doses from CT examinations. Phys Med Biol (1999) 1.09
Atherogenesis in transgenic mice with human apolipoprotein B and lipoprotein (a). J Clin Invest (1995) 1.08
Characterization of a nested polymerase chain reaction assay for detection of parvovirus B19. J Clin Microbiol (1993) 1.07
Mildly oxidized low density lipoprotein activates multiple apoptotic signaling pathways in human coronary cells. FASEB J (2000) 1.07
Abundant expression of apoprotein E by macrophages in human and rabbit atherosclerotic lesions. Arterioscler Thromb (1993) 1.06
Effect of probucol treatment on gene expression of VCAM-1, MCP-1, and M-CSF in the aortic wall of LDL receptor-deficient rabbits during early atherogenesis. Arterioscler Thromb Vasc Biol (1997) 1.05
Immunological responses to oxidized LDL. Free Radic Biol Med (2000) 1.04
High-fat, high-cholesterol diet increases the incidence of gastritis in LDL receptor-negative mice. Arterioscler Thromb Vasc Biol (2001) 1.02
An animal model to study local oxidation of LDL and its biological effects in the arterial wall. Arterioscler Thromb Vasc Biol (1998) 1.02
Intracellular localization of an active green fluorescent protein-tagged Pho84 phosphate permease in Saccharomyces cerevisiae. FEBS Lett (1999) 1.01
Unusually high concentrations of sialic acids on the surface of vascular endothelia. Br J Exp Pathol (1985) 1.01
Totally implantable vascular access in treatment of cystic fibrosis. Lancet (1986) 1.00
New evidence for beneficial effects of statins unrelated to lipid lowering. Arterioscler Thromb Vasc Biol (2001) 1.00
The effects of intravenous clonidine on ventilation. Anaesthesia (1991) 0.99
Diagnostic x-ray spectra: a comparison of spectra generated by different computational methods with a measured spectrum. Med Phys (1998) 0.99
Immunomodulation: a new role for statins? Nat Med (2000) 0.99
Evidence for oxidative activation of c-Myc-dependent nuclear signaling in human coronary smooth muscle cells and in early lesions of Watanabe heritable hyperlipidemic rabbits: protective effects of vitamin E. Circulation (2000) 0.98
Lipoproteins in normal and atherosclerotic aorta. Eur Heart J (1990) 0.97
Maternal hypercholesterolemia during pregnancy influences the later development of atherosclerosis: clinical and pathogenic implications. Eur Heart J (2001) 0.96
Phosphate permeases of Saccharomyces cerevisiae. Biochim Biophys Acta (1998) 0.94
Influence of platelet activation of erythrocyte deformability. Thromb Haemost (1983) 0.94
Effect of the antioxidant N,N'-diphenyl 1,4-phenylenediamine (DPPD) on atherosclerosis in apoE-deficient mice. Arterioscler Thromb Vasc Biol (1995) 0.93
SNP discovery and genetic mapping of T-DNA insertional mutants in Fragaria vesca L. Theor Appl Genet (2010) 0.91
A new approach to determining the rates of recruitment of circulating leukocytes into tissues: application to the measurement of leukocyte recruitment into atherosclerotic lesions. Proc Natl Acad Sci U S A (1997) 0.90
Effect of probucol on LDL oxidation and atherosclerosis in LDL receptor-deficient mice. J Lipid Res (1998) 0.90
Evidence for oxidatively modified lipid-protein complexes in endometrium and endometriosis. Fertil Steril (1998) 0.88
Anticardiolipin antibodies from patients with the antiphospholipid antibody syndrome recognize epitopes in both beta(2)-glycoprotein 1 and oxidized low-density lipoprotein. Circulation (2001) 0.87
Fatty acid ethyl esters are present in human serum after ethanol ingestion. J Lipid Res (1994) 0.86
A 5-year clinical review of bond failure with a light-cured resin adhesive. Angle Orthod (1998) 0.86
Abnormal iron deposition associated with lipid peroxidation in transgenic mice expressing interleukin-6 in the brain. J Neuropathol Exp Neurol (1998) 0.85
Pre-oxygenation: the Hudson mask as an alternative technique. Anaesthesia (1992) 0.85
Concomitant release of sialic acids and calcium by neuraminidase from rat aorta in situ. Proc R Soc Lond B Biol Sci (1988) 0.84
A comparison of radiation dose measured in CT dosimetry phantoms with calculations using EGS4 and voxel-based computational models. Phys Med Biol (1997) 0.84
Laboratory evaluation of a compomer and a resin-modified glass ionomer cement for orthodontic bonding. Angle Orthod (1999) 0.83
Neo-self antigens and the expansion of B-1 cells: lessons from atherosclerosis-prone mice. Curr Top Microbiol Immunol (2000) 0.83
Inhibition of VCAM-1 expression in the arterial wall is shared by structurally different antioxidants that reduce early atherosclerosis in NZW rabbits. J Lipid Res (1999) 0.83
Macrophages, endothelial cells, and lipoprotein oxidation in the pathogenesis of atherosclerosis. Toxicol Pathol (1990) 0.82
Functions, regulation and cellular localization of plant cyclin-dependent kinase inhibitors. J Microsc (2008) 0.82
Macrophage scavenger receptor(s) and oxidatively modified proteins in endometriosis. Fertil Steril (1998) 0.81
Effect of vitamin E on atherogenesis in LDL receptor-deficient rabbits. Atherosclerosis (1995) 0.81
Are immunological mechanisms relevant for the development of atherosclerosis? Clin Immunol (1999) 0.81
Increased microvascular resistance to blood flow in the rat hindlimb after perfusion with neuraminidase. J Physiol (1989) 0.81
Purification of fatty acid ethyl esters by solid-phase extraction and high-performance liquid chromatography. J Chromatogr B Biomed Appl (1996) 0.81
Aminoguanidine has both pro-oxidant and antioxidant activity toward LDL. Arterioscler Thromb Vasc Biol (1995) 0.81
Regression of post-transplant Kaposi's sarcoma using sirolimus. Int J Clin Pract (2006) 0.80
Distortion of intravascular ultrasound images because of nonuniform angular velocity of mechanical-type transducers. Am Heart J (1996) 0.78
Microangiopathic haemolytic anaemia secondary to lupus nephritis: an important differential diagnosis of thrombotic thrombocytopenic purpura. Lupus (2007) 0.78
Pressure-induced metabolic activation of platelets demonstrated in vitro by determination of malondialdehyde formation. Thromb Haemost (1984) 0.77
The measurement of plasma catecholamine and lactate thresholds: a comparison of methods. Eur J Appl Physiol (2000) 0.76
Impaired neutrophil killing in a patient with defective degranulation of myeloperoxidase. J Clin Lab Immunol (1988) 0.76
Determination of atherogenesis in apolipoprotein E-knockout mice. Nutr Metab Cardiovasc Dis (2000) 0.76
The effect on dose to computed tomography phantoms of varying the theoretical x-ray spectrum: a comparison of four diagnostic x-ray spectrum calculating codes. Med Phys (1998) 0.76
Introduction. Emerging infections: what have we learnt from SARS? Philos Trans R Soc Lond B Biol Sci (2004) 0.75
Early and late reactions in contact sensitivity in the mouse. Int Arch Allergy Appl Immunol (1981) 0.75
Letter: Hodgkin's and lymphoma cases. Med J Aust (1976) 0.75